Bone marrow-derived mouse mast cells were sensitized with monoclonal mouse IgE antibody and treated with cholera toxin (CT), which ADP-ribosylated the a-subunit of the stimulatory guanine nucleotide-binding regulatory protein Gs, prior to challenge with either antigen or thrombin.
The CT treatment increased intracellular cAMP levels, but neither enhanced nor inhibited antigen-induced histamine release or arachidonate release. The same treatment of the sensitized bone marrow-derived mouse mast cells with CT markedly enhanced thrombin-induced histamine release without affecting arachidonate release. The CT treatment failed to affect antigen-induced and thrombin-induced generation of inositol trisphosphate and of diacylglycerol or mobilization of intracellular Ca2". The results indicate that Gs in bone marrow-derived mouse mast cells is not involved in the transduction of the antigen-induced or thrombin-induced triggering signal to phospholipase C, which initiates the enhancement of phosphatidylinositol turnover. The enhancement of thrombin-induced histamine release by CT treatment with the observations that thrombin-induced histamine release was inhibited by pretreatment of the cells with pertussis toxin suggest that the involvement of a guanine nucleotide-binding regulatory protein in thrombin-induced biochemical events is an event distal to Ca2" mobilization.
Mast cells and basophils release inflammatory mediators through the reaction of cell-bound IgE antibodies with multivalent antigen (1) and through various IgE-independent stimuli (2) . Analysis of biochemical events involved in triggering of mediator release revealed that bridging of IgE receptors on mast cells and basophils results in the activation of various membrane-associated enzymes (3) (4) (5) , induces mobilization of intracellular calcium (6, 7) , and an enhancement of phosphatidylinositol (PtdIns) turnover (8, 9) . These results suggested that guanine nucleotide-binding regulatory protein(s) [G protein(s)] are involved in the transduction of receptor-mediated signals to the enzymes. However, our studies have revealed that pretreatment of rodent mast cells and human basophils with pertussis toxin (PT), which ADP-ribosylated the G protein Gi and other G proteins (10, 11) , failed to affect the IgE-mediated histamine release (12) . The same PT treatment of rodent mast cells inhibited histamine release induced by thrombin or compound 48/80, and the treatment of human basophils resulted in the inhibition of histamine release by fMet-Leu-Phe in a dose-dependent manner. The present experiments were undertaken to determine the effect of cholera toxin (CT), which ADP-ribosylates the stimulatory G protein G, (13, 14) , on the histamine release. To analyze the effects of the CT treatment on the biochemical events induced by IgE-dependent and IgE-independent stimuli, we employed interleukin 3 (IL-3)-dependent, bone marrow-derived mouse mast cells (BMMC) in which both IgE-dependent and thrombin-induced histamine release were observed (12) .
MATERIALS AND METHODS
Cell Preparations. BMMC were obtained from bone marrow cells of CBA/J mice (The Jackson Laboratory) in suspension culture containing mouse IL-3. The cells were cultured for 4 weeks in RPMI 1640 culture medium (GIBCO), supplemented with 10% (vol/vol) fetal calf serum, 50 mM 2-mercaptoethanol, 2 mM L-glutamine, and antibiotics and enriched with 5% (vol/vol) S15 72F-D11 cell conditioned medium (15) containing mouse IL-3. The cell line was kindly supplied by N. Arai (DNAX Institute of Molecular Biology, Palo Alto, CA). More than 95% of nonadherent cells in the culture were mast cells, and their viability was >99%.
IgE Antibodies and Antigen. Purified monoclonal mouse IgE anti-DNP antibody and dinitrophenyl derivatives of human serum albumin (DNP-HSA) were the same preparations as those described (5) . The conjugate contained 13 dinitrophenyl groups per human serum albumin molecule.
Passive Sensitization and Histamine Release. BMMC were sensitized by incubation overnight with monoclonal mouse IgE antibody at 10 ,ug/ml at 37°C. After washing, the cells were resuspended in Tyrode solution (pH 7.4) containing 124 mM NaCI, 4 mM KCl, 0.64 mM NaH2PO4, 1.6 mM CaC12, 1 mM MgCl2, 10 mM NaHCO3, 5.5 mM glucose, 10 mM Hepes, 5 mM Mes, and 0.1% gelatin. A suspension of the sensitized cells (5 x 105 to 106 cells per ml) was incubated at 37°C with an optimal concentration (0.01 ,g/ml) of DNP-HSA for maximum histamine release (12) . Under this condition, 40-70% of histamine was released within 5 min. The same cell suspensions were also incubated with optimal concentration (0.5 unit/ml) of thrombin (bovine plasma, Boehringer Mannheim), which gave 10-30% histamine release. Histamine content in the medium supernatant was measured by the automated technique of Siraganian (16) .
Intracellular cAMP levels in the cells were determined by radioimmunoassay as described (17) .
Treatment of Mast Cells with CT and Identification of CT-Mediated ADP-Ribosylated Membrane Protein. A suspension of sensitized BMMC in Tyrode solution was incu-bated with CT at 0.1 ng/ml to 1 tkg/ml at 370C for 3 hr.
ADP-ribosylation of the G protein by the CT treatment was determined as described (12) . Briefly, the CT-treated and untreated cells were homogenized to obtain the particulate fraction. G protein in the fraction was then ADP-ribosylated in the presence of [a-32P]NAD and of 100 ,tM GTP by CT that had been activated with 20 mM dithiothreitol and 2 mM Mg-ATP. After incubation for 60 min at 30'C, the particulate fraction was dissolved in NaDodSO4 and analyzed by NaDodSO4/PAGE. ADP-ribosylation by activated PT was carried out as described (12) . ADP-ribosylated proteins were detected by autoradiography of the gels (18) .
[14C]Arachidonic Acid (A4Ach) Release (16.9 Ci/mmol, Amersham), and the suspension was incubated for 12-20 hr at 37°C in a humid atmosphere of 5% C02/95% air.
After washing, a 200-Al aliquot of the cell suspension (0.5-1 x 107 cells per ml) in Tyrode solution was challenged with either DNP-HSA or thrombin. The reaction was terminated by the addition of 750 ,ul of chloroform/methanol, 1:2 (vol/ vol). The aqueous phase was separated as described (12) , and various [3H]inositol phosphates were separated by anion-exchange chromatography on Dowex-1 formate resin (Sigma) as described by Berridge et al. (20) and Beaven et al. (8) . Detailed procedures and separation of various inositol phosphates have been described (12) . As the standard for inositol 1,4,5-trisphosphate (InsP3), an appropriate dose of D-myo-[2-3H]InsP3 (91.0 Ci/mmol, Amersham) was applied to the Dowex column and eluted in the same sequences as that employed for the separation of inositol phosphates.
Determination of 1,2-Diacylglycerol (acyl2Gro). BMMC was incubated at 37°C overnight in culture medium containing [2-3H]glycerol (1 Ci/mmol, Amersham), at 100 ,uCi per 106 cells per ml and mouse anti-DNP IgE antibody at 10 ,ug/ml. Cells were challenged with either DNP-HSA or thrombin, and the reaction was stopped by the addition of ice-cold chloroform/methanol, 2:1 (vol/vol). Lipids were extracted by the method of Bligh and Dwyer (21) , and analyzed by TLC on Silica G plates (Analtech, Newark, DE) with dichloroethane/ethanol, 98:2 (vol/vol). Radioactivity of the acyl2Gro spot was measured in a scintillation spectrometer.
Measurement of Quin-2 Fluorescence. Sensitized BMMC was loaded with quin-2 tetrakis(acetoxymethyl) ester as described by Tsien et al. (22) , with slight modifications (7). Quin-2 fluorescence was recorded by using an SLM 8000 photon-counting spectrofluorometer with a temperaturecontrolled cuvette (37°C) and a magnetically driven stirrer. Fluorescence excitation and emission wave lengths were 339 nm and 492 nm, respectively. Spectra were processed by using a Hewlett-Packard HP 85 desk computer.
Reagents. CT and CT B subunit were purchased from List Biological (Campbell, CA). 1,2-Dioleoyl-rac-glycerol, prostaglandin El (PGE1), and forskolin were purchased from were identical to those of the a chain of Gs in many types of cells (13, 14, 23) Effects of CT on Histamine Release and A4Ach Release. To determine the possible effects of CT on the antigen-induced and thrombin-induced histamine release, sensitized BMMC were incubated with various concentrations of CT. The cells were washed three times and challenged with either DNP-HSA or thrombin. As shown in Fig. 2 , pretreatment of BMMC with CT resulted in a dose-dependent enhancement of thrombin-induced histamine release but failed to affect the antigen-induced histamine release. The enhancement of thrombin-induced histamine release increased with preincubation period with CT. In three cell preparations, pretreatment with CT at 100 ng/ml for 10 min, 30 (Fig. 2) . It was confinmed that CT treatment neither enhanced nor inhibited 20-3W5o of the histamine release induced by a 'suboptimal concentration (0.1 ng/ml) of DNP-HSA. Incubation of BMMC with CT resulted in a dose-dependent increase in intracellular cAMP (Fig. 2) . The increase in cAMP also depends,on incubation period with CT. In the same' three cell 'preparations described above, which were incubated with. CT at 100 ng/ml for 3 hr, intracellular cAMP levels increased from 2.9 ± 1.1 pmol per 107 cells to 7.3 ± 1.6 pmol per 107 cells, and this level was maintained at least 30 min after removal of CT.
To prove thtteehnmnto the thrombin-induced histamine release by-CT treatment depends on the ADPribosyltranisferase activity of CT, we determined the effect of the B subunit of CT, which binds to the cells but lacks the enzyme activity (24) Effect of CT Treatment on Thrombin-Induced and AntigenInduced Inositol Phospholipid Hydrolysis. To determine the possible role of the stimulatory G protein GS in thrombininduced histamine release, we determined the effects of CT treatment on thrombin-induced PtdIns turnover. The experiments were designed based on the kinetics of the generation of InsP3, inositol bisphosphate (InsP2), and inositol phosphate (InsP) after the addition of thrombin at 0.5 unit/ml to sensitized BMMC (12) . Thus, a suspension of sensitized BMMC was divided into three portions, and an aliquot of the suspension was labeled with myo-[3H]inositol for the analysis of InsP3, InsP2, and InsP. The second portion of the cells was labeled with [3H]glycerol for the determination of acyl2-Gro, and the remainder was used for histamine release. Each of the three cell suspensions was incubated with various concentrations of CT for 3 hr. After washing, both the CT-treated and untreated cells were challenged with thrombin at 0.5 unit/ml. Since the generation of InsP3 and InsP2 after exposure to thrombin was transient, reached maximum at 15 sec and then declined, while InsP generation reached plateau at 1 min (12), the reaction was stopped at 15 sec for the determination of InsP3 and InsP2, and at 1 min for the determination of InsP. Based on reported data that the kinetics of the thrombin-induced acyl2Gro formation paralleled histamine release (12), acyl2Gro and histamine were measured at 10 min. The results of three experiments are summarized in Fig. 3 . It is apparent that pretreatment of BMMC with CT at 10 ng/ml to 1 ,ug/ml neither enhances nor inhibits the thrombin-induced generation of InsP3, InsP2, InsP, or acyl2Gro. Similar experiments were carried out to determine possible effects of CT treatment on antigen-induced PtdIns turnover. As expected, preincubation of the cells with CT at 1 ,ug/ml for 3 hr did not affect the antigeninduced generation of InsP3, InsP2, InsP), or acyl2Gro (results not shown).
Failure of CT treatment to affect the PtdIns turnover was confirmed by determination of quin-2 signal. In the experiments shown in Fig. 4 , sensitized BMMC were incubated with CT at 1 ,ug/ml or in Tyrode solution for 3 hr, and the cells were loaded with quin-2 tetrakis(acetoxymethyl) ester. Addition of either thrombin at 0.5 unit/ml or DNP-HSA at 0.01 jig/ml increased quin-2 fluorescence. It is apparent in histamine release. It was also found that 8BrcAMP failed to affect the generation of InsP3, InsP2, InsP, and acyl2Gro induced by either thrombin or antigen. Thus, the effects of 8BrcAMP on BMMC were similar to those obtained by CT treatment. However, pretreatment with PGE1 and forskolin, which also increased intracellular cAMP level, gave entirely different effects on histamine release. Intracellular cAMP levels in three BMMC preparations increased from 1.6 ± 0. 
DISCUSSION
Data presented in this paper show that treatment of BMMC with CT at 1 Ag/ml, which ADP-ribosylated 95% of a subunit of the stimulatory G protein Gs, neither inhibited nor enhanced IgE-mediated histamine release or A4Ach release. These findings with our observations that treatment of BMMC or IL-3-dependent mouse mast cell line PT-18 cells (25) with PT, which ADP-ribosylated >97% of the a subunit of the inhibitory G protein Gi, failed to affect the IgEmediated histamine and A4Ach release (12) , suggest strongly that neither G0 nor Gs is involved in the process of IgEdependent mediator release. In contrast, histamine release from BMMC by thrombin, an IgE-independent secretagogue, was markedly enhanced by pretreatment of the cells with CT (Fig. 2) and inhibited by pretreatment with PT (12) . It should be noted, however, that neither the CT treatment nor PT treatment affected the thrombin-induced A4Ach release. It Biochemistry: Saito et al.
Proc. Natl. Acad. Sci. USA 85 (1988) has been believed that biochemical processes for histamine release and those for A4Ach release may share common triggering events. Discrepancies in the effect of CT (and PT) treatment between thrombin-induced histamine release and thrombin-induced A4Ach release suggest that G protein(s) may be involved in the reactions in the degranulation process that are not shared by A4Ach release. Indeed, neither CT treatment (Fig. 3) nor PT treatment (12) of BMMC affected the thrombin-induced generation of InsP3 and acyl2Gro or mobilization of intracellular Ca2 +. These findings suggest that CT-sensitive G protein as well as PT-sensitive G protein may be involved in the biochemical processes distal to the increase in intracellular Ca2 + . This is in agreement with the hypothesis by Fernandez et al. (26) who demonstrated that introduction of guanosine 5'-[y-thio]triphosphate and MgATP into mast cells caused degranulation. They suggested that stepwise increase in the cell membrane capacitance during the degranulation process of mast cells is due to the fusion of individual secretory granules with the plasma membrane and that G protein(s) are involved in the control of this process.
Since CT treatment of BMMC induces an increase in intracellular cAMP, the possibility was considered that an enhancement of thrombin-induced histamine release was a consequence of an increase in cAMP levels. Indeed, 8BrcAMP mimicked the effect of CT by enhancing thrombininduced histamine release without affecting the IgE-mediated histamine release or thrombin-induced PtdIns turnover. However, a 2-fold increase of cAMP levels in BMMC by PGE1 failed to affect both thrombin-induced and antigen-induced histamine release. Furthermore, treatment with forskolin, which also increased intracellular cAMP by 2-to 3-fold, inhibited antigen-induced histamine release and PtdIns turnover. It is not known why these reagents, all of which increased cAMP levels, exerted entirely different effects on mediator release from BMMC. Nevertheless, the results did not provide definitive evidence that the enhancement of thrombin-induced histamine release by CT treatment is the consequence of an elevation of cAMP levels.
Evidence suggests that G proteins are involved in the receptor-mediated signal transduction in various types of cells, such as neutrophils. Preincubation of neutrophils with PT resulted in the inhibition of ligand-mediated PtdIns turnover and mobilization of intracellular Ca2+ (27, 28) . In both IgE-dependent mediator release and thrombin-induced mediator release from BMMC, however, neither CT treatment nor PT treatment (12) of the cells affected the enhancement of PtdIns turnover or mobilization of intracellular Ca2 .
The results indicate that neither CT-sensitive G protein (G.) nor PT-sensitive G protein (Gi or G.) is involved in the transduction of triggering signals to phospholipase C, which initiates the enhancement of PtdIns turnover. However, it is still possible that a distinct G protein in mast cells/basophils is involved in signal transduction for mediator release. Gomperts (29) demonstrated that introduction of nonhydrolyzable GTP analogues into rat mast cells caused histamine release in response to extracellular Ca2 .
It has been shown that IgE-dependent histamine release from human basophils and rat mast cells was inhibited by pretreatment of the cells with reagents that increased intracellular cAMP (30, 31) . Lichtenstein et al. (32) reported that IgE-dependent histamine released from human basophils was inhibited by pretreatment of the cells with CT and speculated that the level of intracellular cAMP regulated histamine release. Indeed, we found that preincubation of cultured human basophils (33) with CT at 1 ng/ml to 1 ,ug/ml for 3 hr resulted in a dose-dependent increase in cAMP and inhibition of IgE-mediated histamine release. Since other reagents that induce elevation of intracellular cAMP, such as forskolin, also inhibited IgE-mediated histamine release from human basophils, inhibition of IgE-mediated histamine release by CT treatment of human basophils may be a consequence of an increased cAMP. It is not known why an increase in cAMP induced by CT treatment inhibited IgE-mediated histamine release from human basophils but not the IgE-mediated histamine release from BMMC. Nevertheless, the findings in human basophils do not provide the evidence that the stimulatory G protein G. is involved in the transduction of IgEmediated triggering signal for mediator release.
